Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  2633

  PDF: 1361
• 

  Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

  A. Loi, S. Lisci, A. Denotti, A. Cauli

  121-125

  24-07-2013

  https://doi.org/10.4081/reumatismo.2013.121

  2877

  PDF: 1033
• 

  Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

  Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan

  26-06-2025

  https://doi.org/10.4081/reumatismo.2025.1792

  217

  PDF: 69
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.875

  1842

  PDF: 899

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 518
• 

  Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

  A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli

  5-10

  https://doi.org/10.4081/reumatismo.2011.5

  2287

  PDF: 1760
• 

  Are biological drugs safe in pregnancy?

  A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

  304-317

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.798

  3723

  PDF: 2400
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1544

  1001

  PDF: 544
• 

  Worry and anger rumination in fibromyalgia syndrome

  A. Ricci, S. Bonini, M. Continanza, M.T. Turano, E.M. Puliti, A. Finocchietti, D. Bertolucci

  195-198

  31-12-2016

  https://doi.org/10.4081/reumatismo.2016.896

  22487

  PDF: 1623

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  745

  PDF: 674

• A short history of anti-rheumatic therapy. II. Aspirin

  G. Pasero, P. Marson

  148-156

  https://doi.org/10.4081/reumatismo.2010.148

  2432

  PDF: 1483

• A short history of anti-rheumatic therapy. I. An introduction on traditional and drug treatments

  G. Pasero, P. Marson

  76-83

  https://doi.org/10.4081/reumatismo.2010.76

  1573

  PDF: 991
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  1789

  PDF: 430

• Long-term survival of methotrexate in psoriatic arthritis

  M. Ricci, G. De Marco, F. Desiati, D. Mazzocchi, L. Rotunno, N. Battafarano, A. Marchesoni

  125-131

  https://doi.org/10.4081/reumatismo.2009.125

  1194

  PDF: 881

• Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience

  F. Giorgetti, M.L. Minnucci, P. Santori, L. Ercoli, M. Rossi, M. Del Papa, G. Morico, P. Squadroni, A. Olivieri, R. Centurioni

  51-56

  https://doi.org/10.4081/reumatismo.2004.51

  1157

  PDF: 1047
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1235

  898

  PDF: 573

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  https://doi.org/10.4081/reumatismo.2007.100

  1475

  PDF: 2087
• 

  Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

  I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

  1-3

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.1

  2273

  PDF: 707

• Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

  E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1608

  1464

  PDF: 535

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  https://doi.org/10.4081/reumatismo.2010.248

  1239

  PDF: 647

• Sanitary costs of osteoarthritis

  G. Leardini, M.T. Mascia, S. Stisi, G. Sandri, M. Franceschini

  316-322

  https://doi.org/10.4081/reumatismo.2001.316

  1043

  PDF: 804

• Methotrexate in the treatment of peripheral arthritis in ulcerative colitis

  R. Peluso, M. Atteno, S. Iervolino, V. Bruner, F. Caso, L. Costa, M. Raimodo, M. Lofrano, F. Manguso, R. Scarpa

  15-20

  https://doi.org/10.4081/reumatismo.2009.15

  1227

  PDF: 927
• 

  Development of thymoma without myasthenia gravis in a patient with radiographic axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

  Piera Altieri, Francesco Maria Mariani, Evy Di Ruscio, Francesco Carubbi, Claudio Ferri, Alessia Alunno

  05-06-2025

  https://doi.org/10.4081/reumatismo.2025.1693

  765

  PDF: 167

• Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine

  L. Cavagna, P. Rossi, L. Bogliolo, E. Antoniazzi, C. Gelmi, R. Caporali, C. Montecucco

  226-231

  https://doi.org/10.4081/reumatismo.2002.226

  2303

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  https://doi.org/10.4081/reumatismo.2005.4s.34

  1131

  PDF: 1125

• Adherence to treatment of osteoporosis: an open question

  M. Varenna, L. Sinigaglia

  4-9

  https://doi.org/10.4081/reumatismo.2009.4

  1271

  PDF: 925
• 

  Efficacy of gluten-free diet in patients with rheumatoid arthritis

  V. Bruzzese, P. Scolieri, J. Pepe

  213-217

  18-01-2021

  https://doi.org/10.4081/reumatismo.2020.1296

  10418

  PDF: 4168

• Polyarticular heterotopic ossification complicating drug induced coma

  S. Antonelli, G.D. Sebastiani

  59-61

  https://doi.org/10.4081/reumatismo.2002.59

  640

  PDF: 816

• The treatment of skin ulcers in patients with systemic sclerosis

  G. Fiori, L. Amanzi, A. Moggi Pignone, F. Braschi, M. Matucci- Cerinic

  225-234

  https://doi.org/10.4081/reumatismo.2004.225

  1376

  PDF: 3534
• 

  Tophi reduction: ultrasound imaging and correlation with plasma levels of uric acid in patients undergoing treatment for tophaceous gout

  A.J.L. Ferrari, A.R. Corrêa Fernandes, R. de Almeida Agustinelli, H. Seike, E. de Ávila Fernandes

  75-80

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1058

  1300

  PDF: 813

• CONVENTIONAL THERAPIES FOR PSORIASIS

  A. Rebora

  77-80

  https://doi.org/10.4081/reumatismo.2007.1s.77

  872

  PDF: 860
• 

  Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

  Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

  27-01-2025

  https://doi.org/10.4081/reumatismo.2025.1694

  1580

  PDF: 19

• Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

  V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

  244-261

  https://doi.org/10.4081/reumatismo.2007.244

  1288

  PDF: 1104

• Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy

  S. Sülükcü, S. Uslu

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1732

  3207

  PDF: 267
• 

  Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review

  F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1571

  1969

  PDF: 1103

• Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

  C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

  209-214

  https://doi.org/10.4081/reumatismo.2007.209

  897

  PDF: 1024

• Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis

  F. Salaffi, A. Stancati, A. Silvestri, M. Carotti, W. Grassi

  161-173

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.161

  2358

  PDF: 2411
• 

  Acute severe gouty arthritis secondary to isotretinoin toxicity in a young male: a case report

  D.S. Meena, D. Kumar, G.K. Bohra

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1566

  2240

  PDF: 672

• The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

  L. Riente

  74-79

  https://doi.org/10.4081/reumatismo.2004.1s.74

  744

  PDF: 887

• Anabolic effects and inhibition of interleukin 6 production induced by neridronate on human osteoblasts

  A. Spreafico, B. Frediani, C. Capperucci, D. Gambera, P. Ferrata, F. Baldi, F. Chellini, S. Niccolini, L. Bocchi, R. Marcolongo

  288-300

  https://doi.org/10.4081/reumatismo.2006.288

  1215

  PDF: 715

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  https://doi.org/10.4081/reumatismo.2004.1s.62

  1267

  PDF: 1907